These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27502717)

  • 41. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
    Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer.
    Matsuo K; Machida H; Mandelbaum RS; Ragab OM; Roman LD; Wright JD
    Gynecol Oncol; 2018 Nov; 151(2):250-256. PubMed ID: 30197062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of distant relapse in patients with FIGO stage IIB-IVA cervical cancer treated with definitive radiotherapy.
    Okazawa-Sakai M; Mabuchi S; Isohashi F; Kawashima A; Yokoi E; Ogawa K; Kimura T
    J Obstet Gynaecol Res; 2017 Nov; 43(11):1743-1750. PubMed ID: 28816403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 45. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
    Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intra-arterial chemotherapy with cisplatin followed by radical radiotherapy for locally advanced cervical cancer.
    Sueyama H; Nakano M; Sakumoto K; Toita T; Takizawa Y; Moromizato H; Kakihana Y; Kushi A; Moromizato H; Higashi M
    Gynecol Oncol; 1995 Dec; 59(3):327-32. PubMed ID: 8522249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
    Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R
    Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation Therapy for Extrapelvic Lymph Node Recurrence After Curative Treatment for Cervical Cancer.
    Uno T; Kanazawa A; Nemoto MW; Harada R; Kobayashi H; Saito M; Iwai Y; Usui H; Mitsuhashi A; Shozu M
    Anticancer Res; 2019 Feb; 39(2):891-895. PubMed ID: 30711972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study.
    Li L; Kou X; Feng X; Zhang M; Chao H; Wang L
    Radiat Oncol; 2015 Sep; 10():189. PubMed ID: 26377326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix.
    Abdallah R; Bush SH; Chon HS; Apte SM; Wenham RM; Shahzad MM
    Int J Gynecol Cancer; 2016 Mar; 26(3):553-60. PubMed ID: 26825841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathologic complete remission after preoperative intracavitary radiotherapy of cervical cancer stage Ib and IIa is a strong prognostic factor for long-term survival: analysis of the Radiumhemmet data 1989-1991.
    Beskow C; Agren-Cronqvist AK; Granath F; Frankendal B; Lewensohn R
    Int J Gynecol Cancer; 2002; 12(2):158-70. PubMed ID: 11975675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion.
    Uno T; Ito H; Isobe K; Kaneyasu Y; Tanaka N; Mitsuhashi A; Suzuka K; Yamazawa K; Shigematsu N; Itami J
    Gynecol Oncol; 2005 Feb; 96(2):335-40. PubMed ID: 15661218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
    Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
    Lee J; Lin JB; Chang CL; Jan YT; Sun FJ; Wu MH; Chen YJ
    Gynecol Oncol; 2017 Jul; 146(1):20-26. PubMed ID: 28457584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Explanation for the failure of neoadjuvant chemotherapy to improve outcomes after radiotherapy for locally advanced uterine cervical cancer from the standpoint of the tumor regression rate.
    Ohara K; Tsunoda H; Tanaka YO; Ohnishi K; Nemoto K; Hashimoto T; Fukumitsu N; Hata M; Sugahara S; Tokuuye K; Yoshikawa H; Akine Y
    Radiat Med; 2007 Feb; 25(2):53-9. PubMed ID: 17541513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
    Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
    Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.